Skip to main content
PMC home page
Skull Base logoLink to Skull Base
. 2002 May;12(2):53–58. doi: 10.1055/s-2002-31566-1

Somatostatin Therapy for Glomus Tumors

A Report of Two Cases

M A Rafferty, R M Walsh, M A Walsh
PMCID: PMC1656918  PMID: 17167644

Abstract

Glomus tumors of the head and neck are benign vascular lesions that often provide dilemmas in management. The presence of somatostatin receptors on the tumor cell surface has facilitated an additional imaging technique in the form of radiolabeled octreotide scanning. The use of the somatostatin analogue, octreotide, also provides a therapeutic option for inoperable or recurrent tumors. We present two patients, one with a surgically inaccessible tumor that recurred after primary radiotherapy and one who underwent incomplete resection because of the tumor's proximity to the internal carotid artery. Neither tumor has shown further growth 5 and 3 years after treatment with octreotide, respectively.

Keywords: Glomus tumors, somatostatin receptor scintigraphy, octreotide

Full text

PDF
53

Images in this article

55FIGURE 1
on p.55
55FIGURE 2
on p.55
56FIGURE 3
on p.56
56FIGURE 4
on p.56
56FIGURE 5
on p.56

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gulya A. J. The glomus tumor and its biology. Laryngoscope. 1993 Nov;103(11 Pt 2 Suppl 60):7–15. doi: 10.1002/lary.1993.103.s60.7. [DOI] [PubMed] [Google Scholar]
  2. Hurst R. D., Modlin I. M. Use of radiolabeled somatostatin analogs in the identification and treatment of somatostatin receptor-bearing tumors. Digestion. 1993;54 (Suppl 1):88–91. doi: 10.1159/000201084. [DOI] [PubMed] [Google Scholar]
  3. Kau R., Arnold W. Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck. Acta Otolaryngol. 1996 Mar;116(2):345–349. doi: 10.3109/00016489609137855. [DOI] [PubMed] [Google Scholar]
  4. Lamberts S. W., Krenning E. P., Reubi J. C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 1991 Nov;12(4):450–482. doi: 10.1210/edrv-12-4-450. [DOI] [PubMed] [Google Scholar]
  5. Lamberts S. W., Reubi J. C., Uiterlinden P., Zuiderwijk J., van den Werff P., van Hal P. Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a. Endocrinology. 1986 Jun;118(6):2188–2194. doi: 10.1210/endo-118-6-2188. [DOI] [PubMed] [Google Scholar]
  6. Manolidis S., Shohet J. A., Jackson C. G., Glasscock M. E., 3rd Malignant glomus tumors. Laryngoscope. 1999 Jan;109(1):30–34. doi: 10.1097/00005537-199901000-00007. [DOI] [PubMed] [Google Scholar]
  7. Mascardo R. N., Sherline P. Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor. Endocrinology. 1982 Oct;111(4):1394–1396. doi: 10.1210/endo-111-4-1394. [DOI] [PubMed] [Google Scholar]
  8. McCaffrey T. V., Meyer F. B., Michels V. V., Piepgras D. G., Marion M. S. Familial paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg. 1994 Nov;120(11):1211–1216. doi: 10.1001/archotol.1994.01880350023005. [DOI] [PubMed] [Google Scholar]
  9. Moe K. S., Li D., Linder T. E., Schmid S., Fisch U. An update on the surgical treatment of temporal bone paraganglioma. Skull Base Surg. 1999;9(3):185–194. doi: 10.1055/s-2008-1058145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Reubi J. C. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth. Acta Endocrinol (Copenh) 1985 May;109(1):108–114. doi: 10.1530/acta.0.1090108. [DOI] [PubMed] [Google Scholar]
  11. Reubi J. C., Laissue J., Krenning E., Lamberts S. W. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):27–35. doi: 10.1016/0960-0760(92)90184-k. [DOI] [PubMed] [Google Scholar]
  12. Schally A. V. Oncological applications of somatostatin analogues. Cancer Res. 1988 Dec 15;48(24 Pt 1):6977–6985. [PubMed] [Google Scholar]
  13. Setyono-Han B., Henkelman M. S., Foekens J. A., Klijn G. M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 1987 Mar 15;47(6):1566–1570. [PubMed] [Google Scholar]
  14. Simko T. G., Griffin T. W., Gerdes A. J., Parker R. G., Tesh D. W., Taylor W., Blasko J. C. The role of radiation therapy in the treatment of glomus jugulare tumors. Cancer. 1978 Jul;42(1):104–106. doi: 10.1002/1097-0142(197807)42:1<104::aid-cncr2820420117>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  15. Telischi F. F., Bustillo A., Whiteman M. L., Serafini A. N., Reisberg M. J., Gomez-Marin O., Civantos F. J., Balkany T. J. Octreotide scintigraphy for the detection of paragangliomas. Otolaryngol Head Neck Surg. 2000 Mar;122(3):358–362. doi: 10.1016/S0194-5998(00)70048-9. [DOI] [PubMed] [Google Scholar]

Articles from Skull Base are provided here courtesy of Thieme Medical Publishers

RESOURCES